The largest database of trusted experimental protocols

4 protocols using hela cells

1

Cell Culture Protocols for Diverse Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
VERO cells, HeLa cells, CHO cells, and human foreskin fibroblasts (HFF) were purchased from the American Type Culture Collection. All cells were maintained at 37°C in a 5% CO2 atmosphere and grown in either Alpha MEM (with Earle’s salts without ribonucleosides, deoxyribonucleosides, and glutamine) or DMEM (with 4.5 g/l glucose and sodium pyruvate without l-glutamine; Corning Cellgro). Unless otherwise stated, media was supplemented with 10% (vol/vol) FBS, 2 mM l-glutamine (Corning Cellgro), and 100 U/ml penicillin plus 100 mg/ml streptomycin (Quality Biological). HeLa cells were transiently transfected using 2 µg plasmid DNA and the Amaxa Nucleofector solution R according to the manufacturer’s instructions using program I-013 (Lonza) or with 0.25 µg plasmid DNA and JetPrime reagent according to the manufacturer’s instructions (Polyplus-transfection SA). To engineer a stable cell line expressing GFP-Rab11A, the GFP-Rab11A plasmid was linearized with ApaL1 and transfected into VERO cells using 2 µg of linearized plasmid, the Amaxa Nucleofector solution R, and program V-01, according to the manufacturer’s instructions. Stable clones were selected with 800 µg/ml G418 sulfate (Corning Cellgro) in Alpha MEM with 20 mM Hepes and cloned in serial dilutions in 96-well plates.
+ Open protocol
+ Expand
2

Functional Assays with Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical vein endothelial cells (HUVECs), human dermal microvascular endothelial cells (HDMECs), human mammary epithelial cells (HMECs), human umbilical artery endothelial cells (HUAEC), human embryonic kidney 293 cells (HEK 293), human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAd), and HeLa cells were obtained from Lonza. All functional assays were performed with HUVECS which were grown at 37 °C in endothelial basal medium (EBM) supplemented with hydrocortisone (1 μg/ml), bovine brain extract (12 μg/ml), gentamicin (50 μg/ml), amphotericin B (50 ng/ml), epidermal growth factor (10 ng/ml) (Lonza), and 10% fetal bovine serum (FBS, Perbio). Transfections of siRNA were performed using the GeneTrans II (MoBiTec) reagent according to the manufacturer’s protocols.
Except for scratch-wound assays, all functional assays were performed on fibronectin-plated HUVECs. Briefly, cells were harvested, left 30 min in suspension to recover from trypsinization, and seeded onto fibronectin-coated dishes for 30 min.
+ Open protocol
+ Expand
3

HeLa Cell Culture and Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa cells (American Type Culture Collection) were cultured in Dulbecco’s Modified Eagle Medium (Lonza, Catalog #BE12–707F) with 10% fetal bovine serum (Merck Biochrom, Catalog #S0615), 2 mM L-Glutamine (Gibco, Catalog #25030–024), 100 units/mL penicillin and 100 μg/mL streptomycin (Gibco, Catalog #15140–122) at 37 °C and 5% CO2. Cells were transiently transfected using a microporator (Neon Transfection System, Invitrogen) under optimized condition (980 V, 35 ms, 2 pulses) according to the manufacturer’s instructions. Transfected cells were plated on 96-well plate (ibidi, Catalog #89621) and incubated for at least 24 h before experiments.
+ Open protocol
+ Expand
4

Cell Culture and Transfection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
WT and Mbnl1,2 DKO MEFs were gifts from Maurice Swanson. HeLa cells (ATCC), MCF7 cells and WT and Mbnl1,2 DKO MEFs were grown in high-glucose DMEM (Lonza) supplemented with 10% fetal bovine serum (FBS) (Sigma Aldrich) and 1 × penicillin–streptomycin (Sigma Aldrich). HSkM (Life Technologies) cells were grown in HAM F-10 medium (Sigma Aldrich) supplemented with 20% FBS, 1 × penicillin–streptomycin, 0.39 µg/mL dexamethasone (Sigma Aldrich) and 10 ng/mL epidermal growth (Sigma Aldrich). All cells were grown at 37 °C and an atmosphere containing 5% CO2. Prior to transfection, the cells were plated in 6-well or 12-well plates and transfected at 50–60% confluence with plasmids using Lipofectamine 3000 (Thermo Fisher) or with siRNA or antisense oligonucleotides using Lipofectamine RNAiMAX (Thermo Fisher) according to the manufacturer’s protocol. Genes were knocked down with siRNAs against MBNL1, MBNL2, DDX5, DDX17 or control siRNA was used (siCtrl) [9 (link), 37 (link)] (Sigma Aldrich) at 50 nM. SSOs with 2′-O-methoxyethyl-phosphorothioate (2′MOE-PS) modification, SSO-e7 and SSO-Ctrl, were used at 25 nM. Cotransfection with 200 ng of the ATP2A1 e22 minigenes and 250 ng of pEGFP-MBNL1-41 expression vector was preceded by siRNA treatment and  4 h of incubation period. The cells were harvested 48 h after transfection. The siRNA and SSO sequences are listed in Suppl. Table S1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!